Meta Biomed Co., Ltd. (KOSDAQ:059210)
3,530.00
-10.00 (-0.28%)
At close: Jun 10, 2026
Meta Biomed Revenue
Meta Biomed had revenue of 24.42B KRW in the quarter ending March 31, 2026, a decrease of -11.84%. This brings the company's revenue in the last twelve months to 99.67B, up 0.44% year-over-year. In the year 2025, Meta Biomed had annual revenue of 102.95B with 9.48% growth.
Revenue (ttm)
99.67B
Revenue Growth
+0.44%
P/S Ratio
0.93
Revenue / Employee
326.79M
Employees
305
Market Cap
92.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 102.95B | 8.92B | 9.48% |
| Dec 31, 2024 | 94.04B | 10.94B | 13.16% |
| Dec 31, 2023 | 83.10B | 14.16B | 20.54% |
| Dec 31, 2022 | 68.94B | 10.16B | 17.29% |
| Dec 31, 2021 | 58.78B | 13.78B | 30.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DYPNF Co.,Ltd | 363.17B |
| H.PIO | 266.01B |
| Daebongls.Co.,Ltd. | 105.19B |
| Com2uS Holdings | 92.02B |
| Sewoon Medical | 64.49B |
| Amicogen | 43.44B |
| 4by4 Inc | 34.27B |
| NFC Corporation | 34.07B |